Latest News about VRTX
Recent news which mentions VRTX
Alleged Industrial Espionage Makes an Interesting Story
June 21, 2023
From Motley Fool
Buying This Growth Stock Hand-Over-Fist Right Now Could Make You a Lot Wealthier by 2030
June 21, 2023
From Motley Fool
Is CRISPR Therapeutics Stock a Buy Now?
June 21, 2023
From Motley Fool
From InvestorPlace
From Motley Fool
How to Retire Rich: Biotech Stocks Edition
June 18, 2023
From InvestorPlace
2 Market-Beating Stocks With Major Catalysts on the Way
June 17, 2023
From Motley Fool
From Motley Fool
From Motley Fool
5 Stocks to Buy With Explosive 500% Potential
June 12, 2023
From InvestorPlace
2 Biotech Stocks That Could Help Make You a Fortune
June 12, 2023
From Motley Fool
3 No-Brainer Stocks to Buy in June
June 10, 2023
From Motley Fool
Breakthrough in CRISPR-Based Therapy: FDA Accepts Vertex and CRISPR Therapeutics' Exa-cel Application
June 09, 2023
From Benzinga
Vertex/CRISPR Partnered Cell Therapy Shows Encouraging In Sickle Cell Disease, Thalassemia Patients
June 09, 2023
From Benzinga
Why Is CRISPR Therapeutics (CRSP) Stock Moving Today?
June 09, 2023
From InvestorPlace
2 Top Biotech Stocks to Buy in June
June 09, 2023
From Motley Fool
5 Top Stocks to Buy in June
June 08, 2023
From Motley Fool
From Motley Fool
A New S&P 500 Bull Market Is Nearly Here: 3 No-Brainer Stocks to Buy Sooner Rather Than Later
June 07, 2023
From Motley Fool
3 Top Healthcare Stocks to Buy for June
June 06, 2023
From Motley Fool
Tickers
VRTX
From Motley Fool
From Motley Fool
From Motley Fool
CRISPR Therapeutics: A Galaxy's Worth of Deep Value
May 31, 2023
From Motley Fool
From Benzinga
Tickers
VRTX
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.
Never miss important news. Subscribe to our newsletter.
Register for free